These results suggested that netrin-1 concentration in this interval might be oncogenic for B cells and that the concentration of netrin-1 might have the potentiality to be applied to evaluate the risk of B-ALL tumorigenesis. This evidence concerns the gene NTN1 and precursor B-cell acute lymphoblastic leukemia.